Biotech – the red-hot, high risk investment story

Biotech stocks have been booming over the last few years. Anyone who has invested will have made some very respectable profits. And it's a bull market that's set to continue for some time yet.
 
 
 
 
 
 


Biotech slump is buying opportunity

Biotechnology stocks have fallen into a bear market, leaving plenty of bargain buys on the table.

Biotech’s three biggest innovators

Investors can find a wide range of profitable stocks in the biotech sector. Professional investor Dr Daniel Koller tips three to buy now.

The battle against the bulge

Expanding waistlines are a global health epidemic. Smart investors should fill their boots with the firms that will profit, says Matthew Partridge.

Profit from stem cells - a great leap forward for medicine

From better drug testing to growing whole new organs – stem cell research is leading to some big investment opportunities. Matthew Partridge tips the best stocks to profit.

The companies to back in the war on the superbugs

Bacteria are becoming increasingly resistant to antibiotics – the biotech firms developing alternatives are set to profit handsomely, says Tom Bulford.

The next frontier of 3D printing: your bones

Human body parts can now be ‘printed’ to replace defective ones. Tom Bulford looks at this exciting new technology, and focuses on one small-cap company making remarkable advances.

The next Silicon Valley?

Pioneers of ‘wearable tech’ are predicting a glorious future for their gadgets. What are they, and will they really take off? Simon Wilson reports.

A red hot trust for the brave

This biotech fund has already proved to be a great investment. But if you’ve missed out, Bengt Saelensminde explains why it’s not too late to get on board.

Cash in on the quest for a universal flu vaccine

Influenza is a serious threat to world health. And there is a huge demand for a universal vaccine. Here, Matthew Partridge picks one firm that is well-placed to profit.

The medical breakthroughs that could help us win the war on cancer

Despite advances, the battle against cancer was beginning to look lost. Matthew Partridge looks at the companies that have turned the tide.

Showing page 1 of 6
ScreenHunter_01 Mar. 25 09.51

The latest investment opportunities & how you can profit - sign up to our FREE daily email HERE